jrnl2009

Publication Venue For

  • Erratum to: Metformin reverses established lung fibrosis in a bleomycin model (Nature Medicine, (2018), 24, 8, (1121-1127), 10.1038/s41591-018-0087-6).  24:1627. 2018
  • Metformin reverses established lung fibrosis in a bleomycin model.  24:1121-1131. 2018
  • Verapamil and beta cell function in adults with recent-onset type 1 diabetes.  24:1108-1112. 2018
  • Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia.  24:450-462. 2018
  • VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer.  23:551-555. 2017
  • A chikungunya fever vaccine utilizing an insect-specific virus platform.  23:192-199. 2017
  • Impact of pre-Adapted HIV transmission.  22:606-613. 2016
  • A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance.  22:421-426. 2016
  • Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer.  22:298-305. 2016
  • A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents 2014
  • Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease.  20:536-541. 2014
  • Thioredoxin-interacting protein regulates insulin transcription through microRNA-204.  19:1141-1146. 2013
  • Preventive and therapeutic effects of Smad7 on radiation-induced oral mucositis.  19:421-428. 2013
  • Targeted estrogen delivery reverses the metabolic syndrome.  18:1847-1856. 2012
  • Gene therapy rescues cilia defects and restores olfactory function in a mammalian ciliopathy model.  18:1423-1428. 2012
  • Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells.  18:1248-1253. 2012
  • Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity.  18:595-599. 2012
  • Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma.  17:941-943. 2011
  • Iduna protects the brain from glutamate excitotoxicity and stroke by interfering with poly(ADP-ribose) polymer-induced cell death.  17:692-699. 2011
  • Hecker, Crowe and Thannickal reply:.  17:32-33. 2011
  • Lung stem cells: Looking beyond the hype.  17:788. 2011
  • Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma.  16:793-798. 2010
  • T helper type 1 and 17 cells determine efficacy of interferon-Β in multiple sclerosis and experimental encephalomyelitis.  16:406-412. 2010
  • Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth.  16:219-223. 2010
  • Gene copy number: Learning to count past two.  15:1127-1129. 2009
  • NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury.  15:1077-1081. 2009
  • TGF-Β1-induced migration of bone mesenchymal stem cells couples bone resorption with formation.  15:757-765. 2009
  • Will integrin inhibitors have proangiogenic effects in the clinic?.  15:726. 2009
  • SNO-hemoglobin and hypoxic vasodilation.  14:1009-1010. 2008
  • The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.  14:931-938. 2008
  • Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs.  14:762-766. 2008
  • SNO-hemoglobin is not essential for red blood cell-dependent hypoxic vasodilation.  14:773-777. 2008
  • A MSC-ing link in metastasis?.  13:1289-1291. 2007
  • Fen1 mutations result in autoimmunity, chronic inflammation and cancers.  13:812-819. 2007
  • Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry.  12:972-977. 2006
  • Weathington et al. reply [2].  12:604. 2006
  • Induction of leptin resistance through direct interaction of C-reactive protein with leptin.  12:425-432. 2006
  • A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation.  12:317-323. 2006
  • Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys.  11:1295-1298. 2005
  • Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.  11:1170-1172. 2005
  • Heart transplantation in baboons using α1,3-galactosyltransferase gene-knockout pigs as donors: Initial experience.  11:29-31. 2005
  • Marked prolongation of porcine renal xenograft survival in baboons through the use of α1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue.  11:32-34. 2005
  • Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity.  10:927-934. 2004
  • PKC-α regulates cardiac contractility and propensity toward heart failure.  10:248-254. 2004
  • Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation.  9:1498-1505. 2003
  • Does neutrophil CD38 have a role in Ca++ signaling triggered by β2 integrin? [1] (multiple letters).  8:307-308. 2002
  • Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells.  8:150-156. 2002
  • Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivo.  7:1209-1216. 2001
  • Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1.  7:920-926. 2001
  • Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity.  7:954-960. 2001
  • Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques.  7:1320-1326. 2001
  • Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques.  6:1140-1146. 2000
  • Catalytic activity of antibodies against factor VIII in patients with hemophilia A.  5:1044-1047. 1999
  • Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen.  5:900-906. 1999
  • HIV-1 and HAART: A time to cure, a time to kill.  5:609-611. 1999
  • Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry.  4:1302-1307. 1998
  • Xenotransplantation-caution, but no moratorium [1] (multiple letters).  4:372-373. 1998
  • An essential role for Fas ligand in transplantation tolerance induced by donor bone marrow.  4:333-335. 1998
  • Gastrogenomic delights: A movable feast.  3:1076-1078. 1997
  • Natural painkillers [1].  3:1302. 1997
  • Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line.  3:1280-1284. 1997
  • HIV viral load markers in clinical practice.  2:625-629. 1996
  • Nonstop treatment of cystic fibrosis [2].  2:608-609. 1996
  • Photoreceptor cell rescue in retinal degeneration (rd) mice by in vivo gene therapy.  2:649-654. 1996
  • Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations.  2:467-469. 1996
  • Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH.  2:347-350. 1996
  • Tumor suppressor genes in the TGF-β signaling pathway? Loss of response to TGF-βs may be an important step in the development and progression of cancer. Recent studies show that receptors and proteins involved in TGF-β signaling may act as tumor suppressors.  2:390-391. 1996
  • Genetic origins of protein shape and interaction rules.  1:876-878. 1995
  • Reply to “…but not to protein folding?”.  1:1223. 1995
  • The molecular recognition theory applied to bispecific antibodies...but not to protein folding? [1].  1:1222-1223. 1995